A soft X-Ray Phase-Based Microscope for Biomedical Applications

用于生物医学应用的软 X 射线相位显微镜

基本信息

批准号：
10606563
负责人：
Joseph David Ferrara
金额：
$ 52.12万
依托单位：
RIGAKU AMERICAS CORPORATION
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-05-15 至 2024-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10606563
关键词：
3-Dimensional Arthritis Back Biological Biomedical Research Blood Cancer Center Cardiovascular Diseases Cells Clinical Clinical Research Computer software Databases Disease Progression Elements Evaluation Generations Health Histology Hour Hydration status Image Image Analysis Individual Light Light Microscope Macrophage Malignant Neoplasms Memorial Sloan-Kettering Cancer Center Methods Microscope Modeling Multimodal Imaging Neoplasm Circulating Cells Optics Osteoporosis Outcome Pathologist Penetration Performance Phase Preparation Procedures Process Recommendation Research Research Personnel Resolution Retrieval Roentgen Rays Sampling Scheme Slice Software Tools Source Specimen Stains Structure Synchrotrons System Testing Thick Thinness Three-Dimensional Image Three-Dimensional Imaging Time Tissue Sample Tissue imaging Tissues Visible Radiation X ray microscopy X-Ray Computed Tomography absorption attenuation biomedical imaging cell type cellular imaging contrast imaging data acquisition design efficacy evaluation flexibility image processing imaging modality imaging system improved innovation meter microscopic imaging millimeter multimodality nano new technology optical imaging preclinical study prototype reconstruction simulation soft tissue software development user-friendly

项目摘要

Abstract Biomedical images are typically obtained utilizing optical light or X-rays. Optical light is suitable for thin tissue slices, but not suitable for obtaining quality 3D images of thick tissue. Tissue specimens up to millimeter in thickness provide information about structure, different cell types and their relationships. One of the problems with optical imaging in thick tissue is the scattering of the optical light. X-rays can penetrate thick tissue, but the currently commercially available X-ray microscope imaging systems, such as the XRadia and Rigaku systems, are not optimal for soft tissue imaging. For the Xradia Versa, the lowest energy X-ray spectrum is 30 kVp, which is too high for soft tissue, while in the Xradia Ultra the field of view is only ~60 µm, and 3D imaging requires several hours. In the case of the Rigaku system, absorption contrast is too low even at low energies. We propose to deliver an intensity-modulation phase-based soft X-ray microscope for non-destructive synchrotron-quality imaging of intact biological samples with the following features:  3D, quantitative and multimodal (phase, attenuation, scatter) images  Acquisition times more than 10 times shorter than in XRadia systems  Resolution of hundreds of nm, same as visible light microscopes  Field of view from 5 mm x 5 mm to 1 mm x 1 mm, resolution from 2 µm to less than 0.5 µm  High-contrast images of cell composition  Imaging tissue/cells in their native hydrated state, with no staining and other disrupting preparation procedures  Implementing two low energy X-ray sources: 5.4 keV and 8 keV. The user can switch back and forth between the two options, as well as adjust the resolution dynamically This will be realized by combining intensity-modulation X-ray phase-based imaging (IM XPBI) method with two innovations such as cycloidal CT acquisition and lab-based ptychography. The microscope will be installed at Memorial Sloan Kettering Cancer Center and validated with a database of existing tissue samples. The 3D histology results from the proposed microscope will be compared to histology results from conventional imaging modalities to determine efficacy. Tests will also be carried out to study cancer- associated cells in blood, such as circulating tumor cells and giant cancer-associated macrophage-like cells discovered by Creatv MicroTech. Possibility to obtain high- resolution high-contrast 3D images of cells in their native state will enhance our biomedical research and clinical utility to cancer. This novel technology will be helpful for basic, pre-clinical and clinical studies related to many health conditions, such as cancer, osteoporosis, arthritis, cardiovascular disease and will assist with understanding of how these diseases progress and how they can be treated.

抽象的通常使用光学或X射线获得生物医学图像。光学是适用于薄组织切片，但不适用于获得厚的优质3D图像组织。组织标本的厚度达到毫米，提供有关结构，不同的细胞类型及其关系。光学问题之一厚组织中的成像是光学光的散射。 X射线可以穿透厚组织，但目前可商购的X射线显微镜成像系统，例如作为Xradia和Rigaku系统，对于软组织成像并不是最佳的。为了 Xradia Versa，最低的能量X射线光谱为30 kVp，它太高了组织，而在Xradia Ultra中，视场仅为〜60 µm，而3D成像需要几个小时。对于Rigaku系统，即使在低能。我们建议提供基于阶段的强度调节的软X射线显微镜与完整生物样品的非破坏性同步质量成像以下功能： 3D，定量和多模式（相位，衰减，散射）图像 采集时间比Xradia系统短10倍以上 分辨率数百nm，与可见光显微镜相同 视场从5 mm x 5 mm到1 mm x 1 mm，从2 µm到更少的分辨率大于0.5 µm 细胞组成的高对比度图像 成像其本地水合状态的组织/细胞，没有染色和其他破坏准备程序 实施两个低能X射线来源：5.4 KEV和8 KEV。用户可以在两个选项之间来回切换，并调整分辨率动态这将通过结合强度调节X射线阶段成像（IM）来实现这一点（IM XPBI）具有两项创新的方法，例如循环CT采集和基于实验室 Ptychography。显微镜将安装在纪念斯隆·凯特林癌症中心和用现有组织样品的数据库验证。 3D组织学来自提出的显微镜将与常规成像的组织学结果进行比较确定效率的方式。还将进行测试以研究癌症 - 血液中的相关细胞，例如循环肿瘤细胞和巨大的癌症相关由Creatv Microtech发现的巨噬细胞样细胞。获得高的可能性分辨率高对比度3D细胞的本地状态将增强我们的生物医学研究和癌症的临床实用性。这项新技术将有助于与与许多健康状况，例如癌症，骨质疏松症，关节炎，心血管疾病并将有助于理解这些疾病的进展以及它们如何发展治疗。